SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/24/2025ACC: 0001961289-25-000006
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-18.63K
Net shares
Net seller
$333.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
18.63K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−18.63K
Price / share
$17.90
Trade value
$333.42K
% of position
5.2%
11/20/2025
355.42K→336.80K
Total
Net shares
−18.63K
Net value
-$333.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2025 | F · Tax Withholding | −18.63K | $17.90 | $333.42K | 5.2% | 355.42K | 336.80K |
| Total | −18.63K | -$333.42K | ||||||
Derivative Transactions0
No derivative transactions reported